BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 33268597)

  • 1. Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma.
    Limeta A; Ji B; Levin M; Gatto F; Nielsen J
    JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.
    Peters BA; Wilson M; Moran U; Pavlick A; Izsak A; Wechter T; Weber JS; Osman I; Ahn J
    Genome Med; 2019 Oct; 11(1):61. PubMed ID: 31597568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
    Gopalakrishnan V; Spencer CN; Nezi L; Reuben A; Andrews MC; Karpinets TV; Prieto PA; Vicente D; Hoffman K; Wei SC; Cogdill AP; Zhao L; Hudgens CW; Hutchinson DS; Manzo T; Petaccia de Macedo M; Cotechini T; Kumar T; Chen WS; Reddy SM; Szczepaniak Sloane R; Galloway-Pena J; Jiang H; Chen PL; Shpall EJ; Rezvani K; Alousi AM; Chemaly RF; Shelburne S; Vence LM; Okhuysen PC; Jensen VB; Swennes AG; McAllister F; Marcelo Riquelme Sanchez E; Zhang Y; Le Chatelier E; Zitvogel L; Pons N; Austin-Breneman JL; Haydu LE; Burton EM; Gardner JM; Sirmans E; Hu J; Lazar AJ; Tsujikawa T; Diab A; Tawbi H; Glitza IC; Hwu WJ; Patel SP; Woodman SE; Amaria RN; Davies MA; Gershenwald JE; Hwu P; Lee JE; Zhang J; Coussens LM; Cooper ZA; Futreal PA; Daniel CR; Ajami NJ; Petrosino JF; Tetzlaff MT; Sharma P; Allison JP; Jenq RR; Wargo JA
    Science; 2018 Jan; 359(6371):97-103. PubMed ID: 29097493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients.
    Frankel AE; Coughlin LA; Kim J; Froehlich TW; Xie Y; Frenkel EP; Koh AY
    Neoplasia; 2017 Oct; 19(10):848-855. PubMed ID: 28923537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy.
    Olekhnovich EI; Ivanov AB; Babkina AA; Sokolov AA; Ulyantsev VI; Fedorov DE; Ilina EN
    mSystems; 2023 Apr; 8(2):e0102322. PubMed ID: 36809182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting cancer immunotherapy response from gut microbiomes using machine learning models.
    Liang H; Jo JH; Zhang Z; MacGibeny MA; Han J; Proctor DM; Taylor ME; Che Y; Juneau P; Apolo AB; McCulloch JA; Davar D; Zarour HM; Dzutsev AK; Brownell I; Trinchieri G; Gulley JL; Kong HH
    Oncotarget; 2022; 13():876-889. PubMed ID: 35875611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma.
    Usyk M; Pandey A; Hayes RB; Moran U; Pavlick A; Osman I; Weber JS; Ahn J
    Genome Med; 2021 Oct; 13(1):160. PubMed ID: 34641962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIGIT
    Tsakmaklis A; Farowski F; Zenner R; Lesker TR; Strowig T; Schlößer H; Lehmann J; von Bergwelt-Baildon M; Mauch C; Schlaak M; Knuever J; Schweinsberg V; Heinzerling LM; Vehreschild MJGT
    BMC Cancer; 2023 Nov; 23(1):1160. PubMed ID: 38017389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metagenome-wide association of gut microbiome features for schizophrenia.
    Zhu F; Ju Y; Wang W; Wang Q; Guo R; Ma Q; Sun Q; Fan Y; Xie Y; Yang Z; Jie Z; Zhao B; Xiao L; Yang L; Zhang T; Feng J; Guo L; He X; Chen Y; Chen C; Gao C; Xu X; Yang H; Wang J; Dang Y; Madsen L; Brix S; Kristiansen K; Jia H; Ma X
    Nat Commun; 2020 Mar; 11(1):1612. PubMed ID: 32235826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer.
    Zhao Z; Fei K; Bai H; Wang Z; Duan J; Wang J
    Thorac Cancer; 2021 Jan; 12(1):66-78. PubMed ID: 33111503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma.
    Wind TT; Gacesa R; Vich Vila A; de Haan JJ; Jalving M; Weersma RK; Hospers GAP
    Melanoma Res; 2020 Jun; 30(3):235-246. PubMed ID: 31990790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma.
    Lee KA; Thomas AM; Bolte LA; Björk JR; de Ruijter LK; Armanini F; Asnicar F; Blanco-Miguez A; Board R; Calbet-Llopart N; Derosa L; Dhomen N; Brooks K; Harland M; Harries M; Leeming ER; Lorigan P; Manghi P; Marais R; Newton-Bishop J; Nezi L; Pinto F; Potrony M; Puig S; Serra-Bellver P; Shaw HM; Tamburini S; Valpione S; Vijay A; Waldron L; Zitvogel L; Zolfo M; de Vries EGE; Nathan P; Fehrmann RSN; Bataille V; Hospers GAP; Spector TD; Weersma RK; Segata N
    Nat Med; 2022 Mar; 28(3):535-544. PubMed ID: 35228751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeepGeni: deep generalized interpretable autoencoder elucidates gut microbiota for better cancer immunotherapy.
    Oh M; Zhang L
    Sci Rep; 2023 Mar; 13(1):4599. PubMed ID: 36944780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut microbiome and melanoma: A review.
    Makaranka S; Scutt F; Frixou M; Wensley KE; Sharma R; Greenhowe J
    Exp Dermatol; 2022 Sep; 31(9):1292-1301. PubMed ID: 35793428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer.
    Peng Z; Cheng S; Kou Y; Wang Z; Jin R; Hu H; Zhang X; Gong JF; Li J; Lu M; Wang X; Zhou J; Lu Z; Zhang Q; Tzeng DTW; Bi D; Tan Y; Shen L
    Cancer Immunol Res; 2020 Oct; 8(10):1251-1261. PubMed ID: 32855157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intestinal microbiome as a predictor of the anti-PD-1 therapy success: metagenomic data analysis].
    Fedorov DE; Olekhnovich EI; Pavlenko AV; Klimina KM; Pokataev IA; Manolov AI; Konanov DN; Veselovsky VA; Ilina EN
    Biomed Khim; 2020 Nov; 66(6):502-507. PubMed ID: 33372909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
    Matson V; Fessler J; Bao R; Chongsuwat T; Zha Y; Alegre ML; Luke JJ; Gajewski TF
    Science; 2018 Jan; 359(6371):104-108. PubMed ID: 29302014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the Gut Microbiome in Hypertension.
    Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
    Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural and Functional Characterization of the Gut Microbiota in Elderly Women With Migraine.
    Chen J; Wang Q; Wang A; Lin Z
    Front Cell Infect Microbiol; 2019; 9():470. PubMed ID: 32083024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis.
    Guo M; Wu G; Tan Y; Li Y; Jin X; Qi W; Guo X; Zhang C; Zhu Z; Zhao L
    mBio; 2023 Feb; 14(1):e0351922. PubMed ID: 36744910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.